{"disease":{"id":"hyperprolactinemia","name":"Hyperprolactinemia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":4,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"dostinex","indication_name":"Hyperprolactinemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Dostinex","company_name":"Par Pharmaceutical, Inc.","drug_phase":"phase_1","molecular_target":"D(1B) dopamine receptor, D(4) dopamine receptor, 5-hydroxytryptamine receptor 1A","drug_class":"","quality_score":27,"revenue":null,"mechanism":null},{"drug_id":"bromocriptine","indication_name":"Hyperprolactinemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Parlodel","generic_name":"BROMOCRIPTINE","company_name":"Esjay Pharma","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"Ergot Derivative","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"cabergoline","indication_name":"Hyperprolactinemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dostinex","generic_name":"CABERGOLINE","company_name":"Pfizer Japan Inc.","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"Ergot Derivative [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"bromocriptin","indication_name":"Hyperprolactinemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bromocriptin","company_name":"University Hospital, Bonn","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 6, Alpha-synuclein, D(1B) dopamine receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03709849","title":"Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":528,"lead_sponsor_name":"Xiyuan Hospital of China Academy of Chinese Medical Sciences","has_results":false},{"nct_id":"NCT04439747","title":"Develop and Implement Methods for Diagnostic and Treatment of Hormonal Disorders in Patients With Chronic Kidney Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Belarusian State Medical University","has_results":false},{"nct_id":"NCT07124221","title":"A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":382,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT00914823","title":"Kisspeptin Administration in the Adult","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05528393","title":"Prolactin and FGF21 in Gestational Diabetes Mellitus","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Shen Qu","has_results":false},{"nct_id":"NCT03569787","title":"Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire","phase":"","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"University Hospitals Coventry and Warwickshire NHS Trust","has_results":false},{"nct_id":"NCT07008417","title":"A Study on Bioequivalence of Cabergoline Tablets in Human Body","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04746313","title":"Prevalence of Hyperprolactinemia in Systemic Scleroderma","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT06326840","title":"Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Taipei Medical University Hospital","has_results":false},{"nct_id":"NCT02956447","title":"Administration of Kisspeptin in Patients With Hyperprolactinemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT03038308","title":"Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Columbia University","has_results":true},{"nct_id":"NCT04146389","title":"Hyperprolactinemia and Adrenal Steroidogenesis","phase":"","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}